| Clinical data | |
|---|---|
| Other names | SC-26304; 7α-Carboxyisopropylspirolactone;17α-Hydroxy-3-oxopregn-4-ene-7α,21-dicarboxylic acid γ-lactone 1-isopropyl ester |
| Routes of administration | Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C26H36O5 |
| Molar mass | 428.569 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dicirenone (INN,USAN; developmental code nameSC-26304; also known as7α-carboxyisopropylspirolactone) is asynthetic,steroidalantimineralocorticoid of thespirolactone group which was developed as adiuretic andantihypertensive agent but was never marketed.[1][2] It wassynthesized andassayed in 1974.[1] Similarly to other spirolactones likespironolactone, dicirenone also possessesantiandrogen activity, albeit with relatively reducedaffinity.[3]
Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |